FTY720-induced human pulmonary endothelial barrier enhancement is mediated by c-Abl.
about
Claudins: Gatekeepers of lung epithelial functionFingolimod Associated Bilateral Cystoid Macular Edema-Wait and See?FTY720 (s)-phosphonate preserves sphingosine 1-phosphate receptor 1 expression and exhibits superior barrier protection to FTY720 in acute lung injury.Differential and opposing effects of imatinib on LPS- and ventilator-induced lung injury.S1P1 receptor modulation preserves vascular function in mesenteric and coronary arteries after CPB in the rat independent of depletion of lymphocytes.Fingolimod prevents blood-brain barrier disruption induced by the sera from patients with multiple sclerosis.SH2 domain-containing protein tyrosine phosphatase 2 and focal adhesion kinase protein interactions regulate pulmonary endothelium barrier function.Junctional protein regulation by sphingosine kinase 2 contributes to blood-brain barrier protection in hypoxic preconditioning-induced cerebral ischemic tolerance.Dengue Virus-Induced Inflammation of the Endothelium and the Potential Roles of Sphingosine Kinase-1 and MicroRNAs.Targeting Abl kinases to regulate vascular leak during sepsis and acute respiratory distress syndrome.Pulmonary endothelial cell barrier enhancement by novel FTY720 analogs: methoxy-FTY720, fluoro-FTY720, and β-glucuronide-FTY720.Imatinib attenuates inflammation and vascular leak in a clinically relevant two-hit model of acute lung injuryRole of FAK in S1P-regulated endothelial permeability.Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury.Junctional complex and focal adhesion rearrangement mediates pulmonary endothelial barrier enhancement by FTY720 S-phosphonateProtein kinase G increases antioxidant function in lung microvascular endothelial cells by inhibiting the c-Abl tyrosine kinase.Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosisDifferential elastic responses to barrier-altering agonists in two types of human lung endotheliumDexamethasone ameliorates H2S-induced acute lung injury by increasing claudin-5 expression via the PI3K pathway.Rho-Kinase Inhibition Ameliorates Dasatinib-Induced Endothelial Dysfunction and Pulmonary Hypertension.19F-NMR-Based Dual-Site Reporter Assay for the Discovery and Distinction of Catalytic and Allosteric Kinase Inhibitors.Ulinastatin Ameliorates Pulmonary Capillary Endothelial Permeability Induced by Sepsis Through Protection of Tight Junctions via Inhibition of TNF-α and Related Pathways
P2860
Q26828514-8B085695-ACD1-4383-8B54-B584C5BA2515Q28068032-6FF9D045-8946-433D-80B5-95FB2E129DEDQ34089093-92C85F21-7120-4336-B9A9-0CD3CE82A892Q35115797-31B808F9-714C-44E1-81AE-42736099C62EQ35167202-AF42FB08-3DC8-4AA5-B5AB-60572759F296Q35578146-DD682DE3-E559-4162-BD85-18D6CFCC11F3Q35816393-AE7FD90E-45B3-4F0B-8371-72A1B416EE58Q36008258-1B9743A7-5638-472A-B366-B6020D88697EQ36280060-D18DB569-1C92-42DF-8976-7A2AD02E2221Q36306823-C5B17BE3-1A74-42A6-BE8C-7D86973D124DQ36306831-92BCF829-2727-4E5D-9852-D4A2F0869523Q36345868-B145A610-E204-4767-ACC1-B7D9089F7844Q36933952-3E696763-58D0-43A7-AE75-649A41176D0DQ37056490-EDE5C84D-31D1-4310-8E81-98915336EA64Q37274794-1B5BA106-FDE6-4052-8A77-E57B6C8C80F4Q37629029-F7B61786-5707-4CBF-B725-B7E7C1E6A5CBQ38216015-AD44912B-2220-4C5A-9D96-F27F08497FB3Q38754799-BA9F4746-002C-48C6-AECA-A19FE3ED7277Q54444326-2AD9E7A5-E5FB-4472-8D4A-7C7C7894DB6FQ54977070-BEED163D-53C7-4318-A2A3-AAB2D5435D11Q54979398-B2BBB5CE-B20A-45A1-853A-F3250AEE1D0FQ58785895-215855FA-4B1B-4835-9656-1CC95147D2CD
P2860
FTY720-induced human pulmonary endothelial barrier enhancement is mediated by c-Abl.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
FTY720-induced human pulmonary endothelial barrier enhancement is mediated by c-Abl.
@en
FTY720-induced human pulmonary endothelial barrier enhancement is mediated by c-Abl.
@nl
type
label
FTY720-induced human pulmonary endothelial barrier enhancement is mediated by c-Abl.
@en
FTY720-induced human pulmonary endothelial barrier enhancement is mediated by c-Abl.
@nl
prefLabel
FTY720-induced human pulmonary endothelial barrier enhancement is mediated by c-Abl.
@en
FTY720-induced human pulmonary endothelial barrier enhancement is mediated by c-Abl.
@nl
P2093
P2860
P1476
FTY720-induced human pulmonary endothelial barrier enhancement is mediated by c-Abl.
@en
P2093
P2860
P356
10.1183/09031936.00047810
P577
2010-11-11T00:00:00Z